Cohort expansion from the phase 1 JEWEL-101 study investigating the tissue factor-targeting antibody-drug conjugate XB002 in patients with advanced solid tumors: Pancreatic and esophageal cancer cohorts.

被引：0

|

作者：

Ulahannan, Susanna Varkey

Johnson, Melissa Lynne

Weiss, Mia C.

Vandross, Andrae L.

Vidal-Cardenas, Sofia Luz

Syed, Mustafa

Tolcher, Anthony W.

机构：

[1] Univ Okahoma, Hlth Sci Ctr, Oklahoma City, OK USA

[2] Sarah Cannon Res Inst, Nashville, TN USA

[3] Washington Univ, Sch Med St Louis, St Louis, MO USA

[4] NEXT Oncol, Austin, TX USA

[5] Exelixis Inc, Alameda, CA USA

[6] NEXT Oncol, San Antonio, TX USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期

关键词：

283-237-6846-271-2644; 3282-3306-2666-3910; 283-324; 298-145-222-184-4809-5347; 283-237-267; 261-566-9263; 283-2494; 4; 2; 14; 1;

D O I：

10.1200/JCO.2024.42.3_suppl.TPS421

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：TPS421 / TPS421

页数：1

相关论文

共 32 条

[31] A phase 1 dose escalation/expansion study of GSK5764227 (GSK'227), a B7-homolog 3 (B7-H3) protein targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors, including gastrointestinal (GI) cancers
Saif, Wasif M.
Cassier, Philippe Alexandre
Curigliano, Giuseppe
Daniele, Gennaro
Hilton, John Frederick
Koganemaru, Shigehiro
Kowalyszyn, Ruben
Lorusso, Patricia
Moreno, Victor
Olmedo Garcia, Maria Eugenia
Perroud, Herman Andres
Symeonides, Stefan N.
Yamamoto, Noboru
Aziez, Amine
Anjum, Rana
Lamacchia, John
Sembhi, Harjeet
Ratia, Nirav
Italiano, Antoine
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS847 - TPS847
[32] BL-M07D1, an antibody- drug conjugate directed to HER2 in patients with locally advanced or metastatic Breast Cancer with HER2-positive/low-expression and other solid tumors: Results from a first-in-human phase 1 study
Song, Erwei
Yao, Herui
Sun, Meili
Zong, Hong
Lin, Rongbo
Zou, Wen
Ding, Muran
Yu, Jing
Xiao, Sa
Wang, Hongwei
Zhu, Hai
Olivo, Martin
Zhu, Yi
CANCER RESEARCH, 2024, 84 (09)

← 1 2 3 4 →